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Abstract 
Panic disorder symptoms are persistent for 50% to 80% of cases even after treatment, resulting in 
experiences of disability and dissatisfaction in life. Previous research has focused on anxiety 
sensitivity (AS) and its dimensions as contributing to symptoms of panic disorder; however, 
recent research has suggested that intolerance of uncertainty (IU) – the tendency for a person to 
consider the possibility of a negative event occurring as threatening, irrespective of the actual 
probability of its occurrence – may also play a critical role. The current study was designed to 
assess the specific relationships between dimensions of IU (i.e., prospective IU and inhibitory 
IU) and the fear and avoidance symptoms associated with panic disorder. Participants included 
122 community members (81% women) with a history of at least one panic attack who 
participated in a larger study on fear. Participants completed measures of AS, IU, and panic 
disorder symptoms. Correlation and regression analyses supported a significant and substantial 
relationship between AS, inhibitory IU, and panic disorder symptoms.  Inhibitory IU accounted 
for relatively more variance in avoidance symptoms related to panic disorder than did the fears 
of physical sensations dimension of AS.  As such, further investigation of the role of IU in panic 
disorder symptoms appears warranted.  Comprehensive results, implications, and directions for 
future research are discussed. 
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Introduction 
Intolerance of uncertainty (IU) is a dispositional characteristic resulting from negative 
beliefs about uncertainty and its implications (Dugas & Robichaud, 2007) wherein the possibility 
of a negative event occurring is considered unacceptable and threatening irrespective of the 
probability of its occurrence (Carleton, Sharpe et al., 2007).  Researchers have increasingly 
agreed that the IU construct also includes prospective (i.e., cognitive perceptions of threat 
pertaining to future uncertainty) and inhibitory (i.e., behavioural symptoms indicating 
apprehension due to uncertainty) dimensions (Birrell, Meares, Wilkinson, & Freeston, 2011; 
Carleton, 2012; Carleton, Norton, & Asmundson, 2007; McEvoy & Mahoney, 2011).  
Substantial evidence has related IU to generalized anxiety disorder (Buhr & Dugas, 2006; 
Koerner & Dugas, 2008; Dugas, Marchand, & Ladouceur, 2005), with early research evidence 
suggesting a specific relationship (Dugas, Schwartz, & Francis, 2004).  More recent research has 
indicated IU may be important for the development and maintenance of all anxiety disorders 
(Carleton, 2012; Carleton, Mulvogue, et al., 2012; Mahoney & McEvoy, 2012-a; 2012-b; 
McEvoy & Mahoney, 2012).  Most of the research to date investigating the relationships 
between IU and various anxiety disorder symptoms has focused on generalized anxiety disorder 
(e.g., Dugas et al., 2005; Dugas et al., 2004), obsessive compulsive disorder (e.g., Holaway, 
Heimberg, & Coles, 2006; Tolin, Abramowitz, Brigidi, & Foa, 2003), and social anxiety disorder 
(e.g., Boelen & Reijntjes, 2009; Carleton, Collimore, & Asmundson, 2010); however, there is 
also reason to expect a relationship between IU, panic attacks, and symptoms of panic disorder. 
Contemporary models of panic disorder suggest that generalized biological and 
psychological vulnerabilities to the development of anxiety, along with a diminished sense of 
control, contribute to the development of panic attacks (Meuret, White, Ritz, Roth, Hofmann, & 
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Brown, 2006; Suarez, Bennett, Goldstein, & Barlow, 2009). Specifically, situational (e.g., state 
anxiety) and subjective (e.g., interpretation of bodily sensations) factors interact with 
predisposing fears of bodily sensations and sensitivity to somatic changes to allow for 
catastrophic misinterpretations of symptoms. These catastrophic misinterpretations culminate in 
physical, emotional, and behavioral responses, which further increase during stress, resulting in a 
self-perpetuating cycle of recurrent and seemingly uncued panic attacks. 
Imbedded in this etiological understanding of panic disorder is anxiety sensitivity – the 
fear of sensations related to anxiety resulting from expectations of catastrophic consequences 
(Reiss & McNally, 1985). People with high levels of anxiety sensitivity are more likely to 
misinterpret bodily sensations as indications of impending threat, which facilitates vulnerability 
to subsequent panic attacks and maintenance of panic disorder (McNally, 2002). Cross sectional 
research has provided indications that people with panic disorder report elevated levels of 
anxiety sensitivity (Taylor, Koch, & McNally, 1992) and prospective naturalistic studies have 
demonstrated that elevated levels of anxiety sensitivity predict the development of panic attacks 
(Maller & Reiss, 1992; Schmidt et al., 1997); moreover, longitudinal research has demonstrated 
that marked reductions in anxiety sensitivity are associated with reductions in panic disorder 
symptoms (Smits, Power, Cho, & Telch, 2004).  Accordingly, anxiety sensitivity has received 
considerable attention in panic disorder research (e.g., Barlow, 1993, 2008; Manfro et al., 2008; 
Reiss & McNally, 1985; Sexton et al., 2003; Starcevic & Berle, 2006).  Researchers have 
recently suggested that the relationship between anxiety sensitivity and catastrophic 
misinterpretations of bodily sensations may be partially explained by difficulties with the 
inherent uncertainty associated with such sensations (Boelen & Carleton, 2012; Carleton, Sharpe, 
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& Asmundson, 2007). As such, IU may represent an important factor involved in the 
development and maintenance of panic disorder symptoms. 
The IU construct may contribute to the development and maintenance of panic disorder 
symptoms as a function of fearing the unknown (Carleton, 2012) in at least two ways.  First, IU 
may influence the interpretation of physical sensations.  For example, heart palpitations are not 
inherently threatening and in some cases are actually sought after (e.g., during exhibition rides or 
as indications of romantic interest); however, if the cause and meaning of the palpitations are 
uncertain, individual capacity to tolerate that uncertainty without catastrophizing becomes 
critical.  Second, several elements of the uncued panic attacks that serve as the hallmark for 
panic disorder (America Psychiatric Association, 2000) are by definition uncertain (e.g., when 
the attack might occur, how long it would last) and, as such, increasing IU can be expected to 
facilitate the anxiety and avoidance associated with panic disorder. For example, concerns about 
having a panic attack suggests elements of prospective IU, whereas changes in behavior relating 
to panic attacks may be related to inhibitory IU.   
Despite the aforementioned theoretical rationale, research exploring the relationship 
between IU and panic disorder remains relatively scant.  The available research indicates that 
patients with a diagnosis of panic disorder (with or without agoraphobia) report IU levels 
generally comparable to patients with other anxiety disorders and significantly higher than 
undergraduate and community samples (Carleton, Mulvogue, et al., 2012; Mahoney & McEvoy, 
2012-a; McEvoy & Mahoney, 2011; 2012).  Beyond that, only two studies (McEvoy & 
Mahoney, 2012; Sexton et al., 2003) have explored the specific relationship between IU and 
symptoms of panic disorder.  Sexton and colleagues (2003) examined the relationship between 
neuroticism, anxiety sensitivity, and symptoms of four anxiety disorders including panic. Results 
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suggested no significant relationship between IU and symptoms of panic; however, the measure 
employed to assess panic symptoms (i.e., Beck Anxiety Inventory; Beck & Steer, 1993) was not 
designed to assess panic per se, and IU was assessed with the original 27-item Intolerance of 
Uncertainty Scale (Freeston et al., 1994), which researchers have found evidence may have a 
worry-specific focus (Gentes & Ruscio, 2011). McEvoy and Mahoney (2012-a) have provided 
initial evidence that the inhibitory dimension of IU partially mediates the relationship between 
neuroticism and panic disorder symptoms in a sample of anxiety disorder patients. The same 
researchers have suggested there may be an important relationship between IU, anxiety 
sensitivity, and panic symptoms, particularly when IU is measured specifically with respect to 
panic symptoms rather than as a trait (Mahoney & McEvoy, 2012-c). One limitation of both 
studies by McEvoy and Mahoney (2012-a) and Mahoney and McEvoy (2012-c) is that they did 
not include measures of anxiety sensitivity so that the relationship between IU, anxiety 
sensitivity, and panic symptoms could be explored. 
The purpose of the current study was to examine the proportion of variance in specific 
fear and avoidance panic disorder symptoms accounted for by dimensions of IU (i.e., prospective 
IU, inhibitory IU) relative to dimensions of anxiety sensitivity (i.e., fear of physical, cognitive, 
socially observable symptoms).  Given increasing evidence supporting IU as a critical 
component of all anxiety disorders (Carleton, 2012), prospective IU and inhibitory IU were 
expected to independently account for a statistically significant proportion of fear and avoidance 
symptoms for panic disorder, above and beyond the relationship with anxiety sensitivity.  
Inhibitory IU was expected to account for more variance in panic disorder symptoms than 
prospective IU, as was the case with previous research (McEvoy & Mahoney, 2012).   
Methods 
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Participants 
A total of 115 participants (83% women) who endorsed having experienced at least one 
panic attack were recruited from across North America through online social media advertising 
to complete a battery of measures online as part of a larger ongoing study.  A power analysis of 
the current results (ƒ
2
= .20, α = .05, number of predictors = 4) suggested that the available 
sample size of 115 is sufficient to provide 95% power to detect real effects in the proposed 
analyses (Erdfelder, Faul, & Buchner, 1996).  The mean age of the current sample was 34 years 
(SD = 13.9 years), and the majority of participants were Caucasian (83%), single/never married 
(49%), had either graduated high school or equivalent (25%) or partial college/university 
education (30%), and were employed full-time (33%).  Potential participants were only excluded 
from the current study if they did not meet age requirements (i.e., 18 to 65 years old) or if they 
had not completed the included measures.  
Procedure 
Participants were recruited from across North America through online social media 
advertising and asked to voluntarily and anonymously complete an Internet-based survey as part 
of a larger ongoing study investigating risk factors and symptoms of anxiety disorders conducted 
between January and August of 2011. Permission to conduct the present study was obtained from 
the local University research ethics board. A total of 1075 participants logged on to complete the 
survey and were presented with measures assessing anxiety disorder risk factors (including AS 
and IU); 357 participants (33%) chose to answer additional questions and were randomized to 
respond to different sets of questions assessing specific anxiety disorder symptoms. 
Questionnaires prior to randomization explored transdiagnostic risk factors for anxiety disorders; 
thereafter, participants were randomized to complete disorder-specific measures to guard against 
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systematic bias and ensure a normal distribution of responses from those with and without salient 
symptoms of that anxiety disorder.  Only 125 participants (35%) were randomized to receive 
questionnaires assessing the presence and severity of panic disorder symptoms; 78 of those 
participants (62%) completed the necessary study measure items. The remaining 37 participants 
completed measures assessing other anxiety disorders and then chose to complete measures 
assessing the presence and severity of panic disorder symptoms. Response validity was assessed 
using two check questions placed randomly within study measures (“I can vividly remember my 
own birth”, “My favorite singer is Marty Bumble”). Participants who responded to the check 
questions with anything other than “not at all” would have been excluded; however, no such 
participants were identified. 
Measures  
Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007).  The ASI-3 is an 18-item self-
report measure assessing the tendency to fear anxiety-related sensations based on the belief that 
they may have harmful or even catastrophic consequences (e.g., “It scares me when I feel faint”).  
Items are rated on a 5-point Likert scale ranging from 0 (very little) to 4 (very much).  Anxiety 
sensitivity includes a physiological, cognitive, and social component, which correspond to fear 
of physical sensations, fear of cognitive dyscontrol, and fear of socially observable reactions, 
respectively.  The ASI-3 has better factorial validity and internal consistency relative to the 
original Anxiety Sensitivity Index (Peterson & Reiss, 1992) and has demonstrated evidence for 
good convergent, discriminate, and criterion-related validity (Taylor et al., 2007).  The internal 
consistency for the total score of the current sample was α = .88.  Internal consistencies for 
subscale scores were α = .82 (physical), α = .91 (cognitive) and α = .79 (social).   
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Intolerance of Uncertainty Scale, Short Form (IUS-12; Carleton, Norton, & 
Asmundson, 2007).  The IUS-12 is a 12-item short-form of the original 27-item Intolerance of 
Uncertainty Scale (Freeston et al., 1994) that measures reactions to uncertainty, ambiguous 
situations, and the future (e.g., “Unforeseen events upset me greatly”).  Items are scored on a 5-
point Likert scale ranging from 1 (not at all characteristic of me) to 5 (entirely characteristic of 
me).  The IUS-12 has a strong correlation with the original scale, r’s = .94 to .96 (Carleton, 
Norton et al., 2007; Khawaja & Yu, 2010).  The IUS-12 has been shown to have two distinct 
factors (Carleton, Norton, et al., 2007; Khawaja & Yu, 2010), prospective IU and inhibitory IU, 
which can be assessed as subscales and possess identically high internal consistencies, α = .85 
(Carleton, Norton et al., 2007).  The psychometric properties of the IUS-12 have all been 
replicated and reified in clinical and nonclinical samples (Carleton, Sharpe et al., 2007; Khawaja 
& Yu, 2010; McEvoy & Mahoney, 2011) with evidence that it is psychometrically comparable to 
the longer original (Khawaja & Yu, 2010).  The internal consistency for the total score of the 
current sample was α = .93.  Internal consistencies for subscale scores were α = .89 (prospective 
IU) and α = .88 (inhibitory IU). 
Panic Disorder Severity Scale (PDSS; Shear et al., 1997).  The panic disorder severity 
scale (PDSS) is a 7-item self-report measure designed to assess symptoms of panic disorder (e.g., 
“During the past week, were there any activities that you avoided or felt afraid of, because they 
caused physical sensations like those you feel during panic attacks?”).  Items are rated on a 5-
point Likert scale ranging from 0 (none) to 4 (extreme).  Four items from the PDSS which 
correspond with symptoms of fear and avoidance were chosen as specific areas of interest for the 
current study.  Panic disorder symptoms examined in the current study included fear of 
symptoms during a panic attack (PDSS-2), fear of future panic attacks (PDSS-3), avoidance of 
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situations for fear of panic attacks (PDSS-4), and avoidance of activities (e.g., physical exertion, 
sexual relations, taking a hot shower or bath, drinking coffee, watching an exciting or scary 
movie) for fear of panic-like symptoms (PDSS-5). The three items assessing frequency (”How 
many panic and limited symptom attacks did you have during the past week?”) and interference 
(“During the past week, how much did [panic symptoms] interfere with your ability to work or 
carry out your responsibility at home?”; “During the past week, how much did panic and limited 
symptom attacks, worry about attacks, and fear of situations and activities because of attacks, 
interfere with your social life?”) of panic disorder symptoms focus more on consequences rather 
than symptoms, and as such were excluded. 
Analyses 
Descriptive statistics and correlation analyses were performed to characterize the data 
and initial interrelationships. To better characterize the current sample, the current data for each 
item were compared to published data for each item from a psychiatric outpatient sample (Shear, 
et al., 2001), diagnosed with current or lifetime Panic Disorder, using independent t-tests.  The 
most recent psychometric research suggests that Likert scales with five or more linear options 
produce measurement results sufficiently comparable to continuous scales for successful use in 
structural equation modelling using individual five point Likert scales (Rhemtulla, Brosseau-
Liard, & Savalei, 2012); as such, we have used hierarchical linear regression with bootstrapping 
for the current study.  Hierarchical linear regressions were performed using each of the 
individual fear (PDSS-2 and 3) and avoidance (PDSS-4 and 5) symptoms of panic disorder as 
dependent variables. PDSS items were inputted as dependent variables individually in order to 
assess panic disorder symptom specific associations with IU and AS. Based on previous theory 
and research (Carleton, Norton et al., 2007; McEvoy & Mahoney, 2011), IUS-12 subscales 
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(prospective IU and inhibitory IU) were entered in step one of the model; thereafter, ASI-3 
subscales (fear of physical sensations, cognitive dyscontrol, and socially observable symptoms) 
were entered in step two.  The order of independent variable placement was based on notions 
that IU may be a necessary, yet distinct, component of AS (Carleton, 2012; Carleton, Norton et 
al., 2007) and that AS is a necessary component of panic symptoms (Barlow, 1993, 2008; 
Taylor, 1999).  Nevertheless, the current study was designed to determine whether IU would 
account for statistically significant and substantial variance beyond that accounted for by other 
independent variables. As such, paralleling prior research (Carleton et al., 2010), analyses were 
also run with AS components in step one and IU subscales in step two in order to thoroughly 
assess the unique contributions of IU to panic disorder symptoms.  
Results 
Descriptive Statistics 
Descriptive statistics for each dependent variable are presented in Table 1.  None of the 
indices of univariate skewness and kurtosis in the community sample were sufficiently out of 
range (i.e., none had positive standardized skewness values that exceeded 2 or positive 
standardized kurtosis values that exceeded 7) to preclude the planned analyses (Curran, West, & 
Finch, 1996; Tabachnick & Fidell, 2013); nevertheless, bootstrapping was used to maximize the 
robustness of the null hypothesis significance tests within the regressions.  Correlational analyses 
(Table 1) suggested statistically significant small to medium relationships between the inhibitory 
IU subscale and PDSS items, ranging from r = .18, p < .01 (PDSS-2) to r = .44, p < .01(PDSS-
4). Correlation coefficients among the prospective IU subscale and PDSS items (i.e., PDSS-2, 
PDSS-3, PDSS-4, and PDSS-5) ranged from r = .08, p = .43 (PDSS-2 to r = .26, p < .01 (PDSS-
3).  Correlation coefficients among ASI-3 dimensions and PDSS items ranged from .08 (ASI-3 
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social and PDSS-2) to .40 (ASI-3 social and PDSS-4). The correlation coefficients between ASI-
3 dimensions and PDSS items in the current study were similar to panic disorder symptom–AS 
correlations reported in the literature (e.g., Grant, Beck, & Davila, 2007; McLeish, Zvolensky, & 
Bucossi, 2007). 
Participants in the current community sample reported lower scores than published  
scores from a psychiatric outpatient sample diagnosed with current or lifetime Panic Disorder 
(Shear, et al., 2001) on the PDSS-2, t(218)=5.45, p<.05, r
2
=.12, and the PDSS-3, t(218)=3.56, 
p<.05, r
2
=.05; however, the differences were not statistically significant for the PDSS-4, 
t(218)=1.23, p>.05, r
2
<.01, or the PDSS-5, t(218)<.01, p>.05, r
2
<.01.  The differences and 
directions were in line with expectations for comparing a community sample to a clinical sample 
and suggest a possible low-end range restriction associated with data from a community sample 
on the PDSS-2 and the PDSS-3.  The relatively lower scores on those two items, while 
statistically significant, were associated with relatively small effect sizes.  Despite the relatively 
small difference, there may be a lower-end range restriction on these items in a non-clinical 
sample, contrasting the higher-end range restriction on these items that would be expected in a 
clinical sample.  In contrast, the comparable scores on items PDSS-4 and PDSS-5 suggest that, in 
community and clinical samples, range restrictions may not be an important differentiating factor 
in assessing panic-related symptoms. 
Hierarchal Linear Regression Analyses 
Comprehensive results for the hierarchal linear regressions are presented in Table 2.  
When placed in step 1, the prospective IU subscale was found to account for non-significant 
amounts of unique variance in three (p = .27, PDSS-2; p = .15, PDSS-4, p = .62, PDSS-5) of four 
analyses. The exception was for the PDSS-3, wherein prospective IU accounted for statistically 
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significant variance (p = .02). When placed in step 2, prospective IU again accounted for 
statistically significant variance for the PDSS-3 (p = .03), but not for the other dependent 
variables (i.e., p = .14, PDSS-2; p = .16, PDSS-4; p = .34, PDSS-5).   The prospective IU 
subscale was identified as a suppressor variable because of the switch in relationship direction 
from the zero-order correlations to the part correlations (see Table 2); accordingly, subsequent 
regressions were performed a second time without the prospective IU subscale.   
Comprehensive results for the hierarchal linear regressions without prospective IU as an 
independent variable are presented in Table 3. For PDSS-2 scores, the inhibitory IU subscale 
accounted for 2% of the variance when entered in step 1 and 1% when entered into step 2, and in 
both cases only trended towards statistical significance.  The ASI-3 subscales also accounted for 
2% of the variance whether entered in step 1 or step 2, most of which came from the fear of 
physical sensations subscale, but none of the subscales were statistically significant.  For PDSS-3 
scores, the inhibitory IU subscale accounted for a statistically significant 9% of the variance 
when entered in step 1, but a non-significant 1% when entered in step 2.  In contrast, the ASI-3 
subscales accounted for a statistically significant 21% of the variance when entered in step 1, 
most of which again came from the fear of physical sensations subscale, as well as a statistically 
significant 13% of the variance when entered in step 2. 
For PDSS-4 scores, the inhibitory IU subscale accounted for a statistically significant 
19% of the variance when entered in step 1, as well as a statistically significant 8% of the 
variance when entered in step 2.  Similarly, the ASI-3 subscales accounted for a statistically 
significant 18% of the variance when entered in step 1, most of which again came from the fear 
of physical sensations subscale, as well as a statistically significant 7% of the variance when 
entered in step 2.  For PDSS-5 scores, the inhibitory IU subscale accounted for a statistically 
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significant 8% of the variance when entered in step 1, but a non-significant 2% when entered in 
step 2.  In contrast, the ASI-3 subscales accounted for a statistically significant 13% of the 
variance when entered in step 1, most of which came from the fear of cognitive dyscontrol 
subscale, as well as a statistically significant 7% of the variance when entered in step 2. 
Discussion 
The current study was designed to assess the specific relationships between IU, AS, and 
the fear and avoidance symptoms of panic disorder in a community sample.  Specifically, the 
variance accounted for by IU and AS in the fear of symptoms during a panic attack, the fear of 
future panic attacks, the situational avoidance stemming from fear of panic attacks, and the 
activity avoidance for fear of panic-like symptoms.  In all cases, IU subscales were expected to 
account for significant variance in panic disorder symptoms beyond the variance accounted for 
by AS dimensions.  The results supported complex associations between IU, AS, and panic 
disorder symptoms. 
Inter-relationships – General 
Inhibitory IU was primarily associated with situational avoidance for fear of panic 
attacks, and to a lesser degree with activity avoidance for fear of panic-like symptoms and fear of 
future panic attacks.  Inhibitory IU demonstrated consistently stronger relationships with fear and 
avoidance symptoms of panic than did prospective IU.  Among those relationships, the strongest 
was between inhibitory IU and avoidance of situations for fear of panic attacks.  The relatively 
strong relationship is consistent with current research suggesting a relationship between IU and 
behaviour (e.g., reward-based decision making [Luhmann et al., 2011], anxiety-drive information 
seeking [Rosen & Knäuper, 2009]), but also theory suggesting a specific relationship between 
inhibitory IU and behavioural avoidance (Carleton, 2012).  Beyond the behavioural relationship, 
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inhibitory IU and the fear of physical sensations were the only two variables to demonstrate a 
significant (but relatively small) relationship with fear of symptoms during a panic attack.  The 
relationship between fear of physical sensations and fear of symptoms during a panic attack is 
congruent with established theory on panic and AS (Deacon & Abramowitz, 2007; Smits et al., 
2004; Taylor, 1999); however, the relationship with inhibitory IU may be the result of overlap 
with the escape aspects (i.e., flight or fight) of fear during a panic attack (Carleton, 2012; Suárez 
et al., 2009).   
As expected, the dimensions of AS were also associated with the fear and avoidance 
symptoms of panic disorder.  The fear of cognitive dyscontrol demonstrated a consistently 
moderate relationship with the panic disorder symptoms, except fear of symptoms during a panic 
attack.  The fear of socially observable reactions demonstrated a similar pattern of relationships 
with the panic disorder symptoms.  Perhaps surprisingly, the fear of physical sensations 
demonstrated relationships with the panic disorder symptoms that were generally comparable to, 
though often smaller than, the other AS dimensions. As such, the pattern of relationships appears 
to suggest that AS, IU, and symptoms of panic have relatively complex associations that warrant 
additional research (Carleton, Sharpe et al., 2007; Deacon & Abramowitz, 2006; Smits et al., 
2004; Taylor, 1999). 
Inter-relationships – Specific 
Assessing the inter-relationships of IU, AS, and panic disorder symptoms served to 
clarify some of the complexities in the pattern of responses.  In all cases prospective IU acted as 
a suppression variable and, as such, was removed from the analyses.  Given the relatively smaller 
relationships between prospective IU and the measured panic disorder symptoms, the 
suppression was most likely a simple function of the relationship between prospective and 
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inhibitory IU.  Unlike prospective IU, inhibitory IU accounted for statistically significant and 
substantial amounts of variance in most of the measured panic disorder symptoms. 
A significant relationship was identified between inhibitory IU and fears of symptoms 
during panic attacks when controlling for anxiety sensitivity, whereas none of the dimensions of 
AS demonstrated such relationships when controlling for IU.  As such, during the panic attack 
itself the symptoms may not be the focus of fear; instead, the behavioral tendency towards 
inaction in the face of uncertainty regarding the symptoms appears to be more prevalent.  The 
relative importance of uncertainty during the panic attack is consistent with previous theory that 
for persons with panic disorder the symptoms are arousing, non-specific, and then interpreted 
catastrophically (Apfeldorf, Shear, Leon, & Portera, 1994; Carleton, Sharpe et al., 2007; Taylor, 
1999); in other words, IU may interact with AS to facilitate panic symptoms by increasing 
distress arising from the non-specific and unknown nature of the physical symptoms.  
 The specific inter-relationships between IU, AS, and fears of future panic attacks were 
somewhat more complex.  Inhibitory IU accounted for the largest single portion of variance; 
however, the fear of physical sensations and the fear of socially observable reactions dimensions 
of AS also accounted for significant and substantial variance.  Based on previous theory 
suggesting that AS requires IU (Carleton 2012; Carleton, Sharpe et al., 2007), the current results 
support the potential importance of IU for fearing future panic attacks.  In addition, the shared 
and unique relationships between inhibitory IU and each of the panic disorder symptoms are 
comparable to or larger than those identified between inhibitory IU and symptoms of social 
anxiety (Carleton et al., 2010). 
Inhibitory IU also accounted for the largest single portion of variance in the situational 
avoidance stemming from fear of panic attacks and the activity avoidance for fear of panic-like 
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symptoms; however, contrasting the relationships with fearing future panic attacks and the 
intuitive expectations based on theories of panic disorder (Apfeldorf et al., 1994; Taylor, 1999), 
fears of physical sensations were not associated with significant variance in either aspect of 
avoidance.  Instead, fears of socially observable reactions accounted for significant and 
substantial additional variance in situational avoidance and fears of cognitive dyscontrol 
accounted for significant, but small, variance in activity avoidance for fear of panic-like 
symptoms.  The results regarding fears of socially observable reactions may be sample-specific 
(e.g., a preponderance of concurrent social anxiety), may reflect an epidemiological overlap 
between symptoms of social anxiety and panic (Kessler, Chiu, Jin, Ruscio, Shear, & Walters, 
2006), or may reflect an inherent embarrassment associated with the experience of panic.  The 
results regarding fears of cognitive dyscontrol may be similarly incidental.  In any case, there 
appears to be evidence that inhibitory IU may play a relatively more important role than fears of 
physical sensations in avoidance related to panic disorder symptoms. 
Limitations and Future Research Directions 
The current study has several limitations that provide directions for future research.  First, 
the data was gathered from an analogue community sample with a history of at least one panic 
attack and, as such, may not generalize to clinical populations.  That said, range restrictions 
associated with exclusively clinical samples might obscure relationships between dimensional 
constructs such as IU (Carleton, Weeks et al., 2012), AS (Broman-Fulks et al., 2008), and panic 
disorder symptoms.  Relatedly, assessing the different panic-related symptoms using individual 
items – even well-established items such as those on the PDSS – may have been insufficiently 
sensitive to demonstrate more complex relationships that may exist.  In any case, the current 
research should be replicated and extended with a clinical population and using items with 
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relatively increased sensitivity.  Second, it is noteworthy that Mahoney and McEvoy (2012-a) 
recently found that situation-specific IU, which was assessed with respect to diagnosis-specific 
concerns (e.g., physical sensations of anxiety for panic disorder) rather than as a trait, was more 
strongly related to panic disorder symptoms than trait IU. In contrast, trait IU was equally or 
more strongly associated with symptoms of other anxiety disorders and depression. Therefore, 
the associations between IU and panic disorder symptoms found in this study may have been 
stronger if IU had have been assessed specifically in relation to uncertain physical sensations. 
Third, the sample was primarily women, which suggests the results may not generalize to men.  
Future research should attempt to include a more demographically balanced sample and assess 
for possible sex differences.   
Fourth, the cross-sectional nature of the data makes causality impossible to determine.  
Given the implicit premise that IU and AS function as vulnerability factors, longitudinal research 
– prospective or intervention-based – will eventually be necessary. Fifth, the frequency and 
number of panic attacks were not assessed; as such, participants included in the current analyses 
may have had varying opportunities to experience panic disorder symptoms. As a result, our 
sample data may be more indicative of panic attacks rather than panic disorder; moreover, in 
collecting only symptom data, assessing relationships between the constructs of interest and an 
aggregated PDSS was not possible.  While this fit well with the intent of the current paper and 
avoided difficulties associated with the items not necessarily being truly additive, future research 
should explore both the aggregate and the individual symptoms.  Sixth, the suppression effect 
noted when both inhibitory and prospective IU were assessed (i.e., prospective IU functioned as 
a suppression variable) warrants additional consideration.  The effect was only statistically 
significant when fear of symptoms during a panic attack served as the dependent variable, and 
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even then the associated variance was relatively small; however, if the same effect is replicated 
in other samples – ideally samples with more variance – it may represent a complex inter-
relationship with important ramifications for theory and practise.  Finally, the current sample did 
report significantly lower scores relative to published scores from a psychiatric outpatient sample 
diagnoses with current or lifetime panic on some, but not all, of the panic disorder symptoms.  
Future research should consider using a mixed sample to further explore not only the construct 
interrelationships identified here, but also the specific relationship of each panic symptom to the 
experience of clinically-significant panic. 
Summary Conclusions 
Despite the aforementioned limitations, the current results extend prior theory and 
research (Carleton 2012; Carleton, Mulvogue, et al., 2012; Carleton, Sharpe et al., 2007; Dugas 
et al., 2001; McEvoy & Mahoney, 2011) with evidence that inhibitory IU is associated with 
symptoms of panic disorder; moreover, for some panic disorder symptoms inhibitory IU may be 
relatively more important than the fear of physical sensations dimension of AS.  Although AS 
emerged as a strong contributor of variance in the current study, the independent contribution of 
inhibitory IU demonstrated in the current results suggests unique and novel associations not 
previously reported. The evidence indicates comparably-sized unique relationships between each 
of IU and the dimensions of AS with respect to each of the panic symptoms, with the inhibitory 
dimension of IU often demonstrating a larger unique relationship than even the physical (i.e., 
somatic) dimension of AS. 
The current results make sense if, as argued previously (Carleton, 2012; Carleton, Sharpe, 
et al., 2007), it is the uncertainty regarding the meaning of the physical sensations that causes the 
associated anxiety; indeed, those same symptoms (e.g., heart palpitations) are often sought out 
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(e.g., rollercoasters, romantic encounters) and experienced as pleasant, so long as there is a 
relatively high level of certainty associated with what is causing the symptoms and what those 
symptoms might indicate.  The fact that the unique relationship between IU and panic symptoms 
was often larger than the unique relationship between AS and panic symptoms suggests that 
increasing tolerance for uncertainty may be a very important clinical target for persons 
experiencing panic symptoms.  Accordingly, treatments addressing both IU (e.g., Dugas & 
Ladouceur, 2000) and AS (e.g., interoceptive exposure) may maximally reduce symptoms of 
panic disorder.  Existing treatments for panic disorder may already be exerting therapeutic 
effects through the incidental and implicit reduction of IU (e.g., engaging in behavioral 
experiments and exposure may expose individuals to situations where they are uncertain of the 
outcome); however, future research is needed to investigate the anxiolytic mechanisms 
associated with reductions in IU among existing treatments. Such therapeutic suppositions 
support evidence indicating that reductions in IU are associated with reductions in symptoms 
during cognitive behavior therapy for social anxiety disorder (Mahoney & McEvoy, 2012-b), 
indicating a parallel pattern may occur for panic disorder symptoms.  Until the supposition is 
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(SE = .23) 
K 
(SE = .45) 
Min, Max 
1.  PDSS-2 1.00 - - - - - - - 1.15 1.32 .65 -.84 0, 4 
2.  PDSS-3 .59** - - - - - - - .77 .97 1.46 1.99 0, 4 
3.  PDSS-4 .40** .57** - - - - - - 1.12 1.22 .76 -.46 0, 4 
4.  PDSS-5 .58** .63** .67** - - - - - .86 1.13 1.21 .65 0, 4 
5.  IUS-12 Pro .08 .16* .26** .19* - - - - 22.31 6.96 -.26 -.67 7, 35 
6.  IUS-12 Inh .18* .30** .44** .29** .78** - - - 14.81 5.41 -.11 -1.20 5, 25 
7.  ASI-3 Cog .15 .34** .30** .32** .33** .33** - - 9.33 7.05 .37 -.97 0, 24 
8.  ASI-3 Soc .08 .34** .40** .25** .24** .35** .49** - 12.74 5.77 -.12 -.65 0, 24 
9.  ASI-3 Phy .19* .37** .22** .26** .36** .31** .37** .32** 9.36 5.93 .23 -.98 0, 22 
Notes.  
*
p < .05, one-tailed; 
**
 p < .01, one-tailed; M = Mean; SD = Standard Deviation; K = Kurtosis; SE – Standard error; min – 
minimum score in current sample; max – maximum score in current sample; IUS-12 – Intolerance of Uncertainty Scale, Short Form; 
ASI-3 – Anxiety Sensitivity Index-3; PDSS – Panic Disorder Symptom Severity Scale; Pro – prospective IU subscale; Inh – inhibitory 
IU subscale; Cog – fear of cognitive dyscontrol subscale; Soc – fear of socially observable reactions subscale; Phy – fear of physical 
sensations subscale. 
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Coefficient statistics Model step statistics 







2 1 (2) IUS-12 Inh .30 (.30) 2.07 (1.98) .03 (.06) .19 (.18) .04(.08) .03(.04) .04(.03) 2.48(2.00) 
  IUS-12 Pro -.16 (-.23) -1.09 (-1.54) .27 (.14) -.10 (-.14)     
 2 (1) ASI-3 Cog .10 (.02) .91 (.91) .38 (.38) .08 (.08) .08(.04) .04(.02) .03(.04) 1.36(1.68) 
  ASI-3 Soc -.08 (-.21) -.69 (-.21) .49 (.84) -.06 (-.02)     
  ASI-3 Phy .16 (.16) 1.58 (1.58) .17 (.18) .15 (.15)     





  IUS-12 Pro -.20 (-.29) -1.41 (-2.16) .02 (.03) -.13 (-.18)     





  ASI-3 Soc .12 (.18) 1.22 (1.85) .16 (.04) .10 (.16)     
  ASI-3 Phy .27 (.26) 2.86 (2.77) .03 (.03) .24 (.23)     





  IUS-12 Pro -.18 (-.19) -1.37 (-1.40) .15 (.16) -.12 (-.11)     





  ASI-3 Soc .23 (.32) 2.36 (3.21) .02 (<.01) .19 (.28)     
  ASI-3 Phy .04 (.08) .45 (.84) .71 (.42) .04 (.07)     
5 1 (2) IUS-12 Inh .35 (.27) 2.41 (1.89) .03 (.08) .22 (.17) .09(.16) .07(.13) .09(.03) 5.22
**
(1.96) 
  IUS-12 Pro -.07 (-.14) -.514 (-1.00) .62 (.34) -.05 (-.09)     





  ASI-3 Soc .05 (.10) .45 (.96) .61 (.32) .04 (.09)     
  ASI-3 Phy .13 (.15) 1.36 (1.53) .33 (.19) .12 (.14)     
Notes. 
*
p < .05; 
**
p < .01; PDSS – Panic Disorder Severity Scale; IUS-12 – Intolerance of Uncertainty Scale, Short Form; ASI-3 – 
Anxiety Sensitivity Index-3; Inh – inhibitory IU subscale; Pro – prospective IU subscale; Cog – fear of cognitive dyscontrol subscale; 
Soc – fear of socially observable reactions subscale; Phy – fear of physical sensations subscale. 
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Coefficient statistics Model step statistics 







2 1 (2) IUS-12 Inh .18 (.13) 1.94 (1.25) .03 (.12) .18 (.12) .03(.06) .02 (.02) .03(.01) 3.76 (1.55) 
 2 (1) ASI-3 Cog .08 (.10) .73 (.91) .25 (.20) .07 (.08) .06(.04) .02 (.02) .03(.04) .96 (1.68) 
  ASI-3 Soc -.05 (-.02) -.46 (-.21) .32 (.42) -.04 (-.02)     
  ASI-3 Phy .14 (.16) 1.32 (1.58) .12 (.08) .12 (.15)     
3 1 (2) IUS-12 Inh .30 (.13) 3.38 (1.41) <.01 (.11) .30 (.12) .09(.23) .09 (.20) .09(.01) 11.43
**
 (1.99) 





  ASI-3 Soc .15 (.18) 1.54 (1.85) .04 (.01) .13 (.16)     
  ASI-3 Phy .23 (.26) 2.47 (2.77) .03 (.02) .21 (.23)     










  ASI-3 Soc .25 (.32) 2.59 (3.21) <.01 (<.01) .21 (.28)     
  ASI-3 Phy .02 (.08) .20 (.84) .43 (.21) .02 (.07)     
5 1 (2) IUS-12 Inh .30 (.17) 3.20 (1.71) <.01 (.08) .29 (.15) .08(.16) .08 (.13) .08(.02) 10.23
**
 (2.91) 





  ASI-3 Soc .06 (.10) .61 (.96) .26 (.16) .05 (.09)     
  ASI-3 Phy .12 (.15) 1.20 (1.53) .18 (.11) .11 (.14)     
Notes. 
*
p < .05; 
**
p < .01; PDSS – Panic Disorder Severity Scale; IUS-12 – Intolerance of Uncertainty Scale, Short Form; ASI-3 – 
Anxiety Sensitivity Index-3; Inh – inhibitory IU subscale; Cog – fear of cognitive dyscontrol subscale; Soc – fear of socially 
observable reactions subscale; Phy – fear of physical sensations subscale. 
